| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jun―03 |
Protective effect of methotrexate against severe forms of COVID-19 in rheumatoid arthritis: A retrospective cohort study |
Freddy Liñán-Ponce, Juan Leiva-Goicochea, Fernando Gross-Melo |
| 2 |
[GO] |
2025―Jun―27 |
RS3PE post-COVID: New evidence of autoimmune diseases following SARS-CoV-2 infection |
Begoña Miquel Veyrat, José Chordá Ribelles, Mar Gómez Martí |
| 3 |
[GO] |
2024―Jul―09 |
Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study |
Laura Cano-García, Sara Manrique-Arija, Rocío Redondo-Rodríguez, Marta Vera-Ruiz, Jose Manuel Lisbona-Montañez, Arkaitz Mucientes-Ruiz, Aimara García-Studer, Fernando Ortiz-Marquez, Natalia Mena-Vázquez, Antonio Fernández-Nebro |
| 4 |
[GO] |
2024―Mrz―16 |
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam |
Hai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, Thi-Ngoc-Lan Nguyen, Jaffar A. Al-Tawfiq, Dinh-Toi Chu |
| 5 |
[GO] |
2023―Dez―04 |
The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report |
Patricia Aguilera-Fernandez, María del Carmen Navarro-Saez, Carlos Feijoo-Massó, Enrique Esteve-Valverde, Sonia Calzado Isbert, Tamara Parra Parente |
| 6 |
[GO] |
2023―Nov―25 |
Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment |
E. Flores-Fernández, I. Vázquez-Gomez, E. Valls-Pascual, C. Valera-Ribera, P. Andújar-Brazal, J.J. Alegre-Sancho |
| 7 |
[GO] |
2023―Okt―13 |
Osteomuscular and autoimmune manifestations of long COVID in Mexico |
Luis Del Carpio-Orantes, Sergio García-Méndez, Andrés Aguilar-Silva, Álvaro Efrén Munguía-Sereno |
| 8 |
[GO] |
2023―Jun―01 |
Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated disease |
Carmen Lobo Rodríguez, Ana M. López-Calleja, Paloma Morales de los Ríos Luna, Susana Sánchez Vázquez, Ángela Molinero Sampedro, Amparo López-Esteban |
| 9 |
[GO] |
2023―Mai―24 |
Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 10 |
[GO] |
2023―Feb―02 |
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 11 |
[GO] |
2023―Feb―02 |
Systemic lupus erythematosus myocarditis after COVID-19 vaccination |
Miguel Sogbe, Andrés Blanco-Di Matteo, I. Madeleine Di Frisco, Juan Fernando Bastidas, Nahikari Salterain, Juan José Gavira |
| 12 |
[GO] |
2022―Nov―24 |
Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: Similarities and differences of two peas in a pod |
Rami Qanneta |
| 13 |
[GO] |
2022―Sep―06 |
Comment to: Teleconsultation of infant rheumatology in COVID-19 time |
Rami Qanneta |
| 14 |
[GO] |
2022―Jun―25 |
Comment: The reality of rheumatology in Spain and its autonomous communities before the pandemic |
Dolors Grados Cànovas, Melania Martínez-Morillo, Alejandro Olivé Marqués |
| 15 |
[GO] |
2022―Jun―24 |
Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection |
Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Juan J. Cruz-Hernández |
| 16 |
[GO] |
2022―Jun―22 |
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment |
Ismael Francisco Aomar-Millán, Juan Salvatierra, José Luis Callejas-Rubio, Enrique Raya-Álvarez |
| 17 |
[GO] |
2022―Mai―11 |
Reactive arthritis with SARS-COV-2 as a trigger |
Víctor Ruiz-del-Valle, Luis Sarabia de Ardanaz, Míriam Navidad-Fuentes, Irene Martín-Martín, Rubén Lobato-Cano |
| 18 |
[GO] |
2022―Mai―11 |
Calcineurin Inhibitors and COVID-19 |
René Hage, Macé M. Schuurmans |
| 19 |
[GO] |
2022―Apr―30 |
The reality of Rheumatology in Spain and its autonomous communities before the pandemic |
Carlos Sánchez-Piedra, José María Álvaro-Gracia, Sagrario Bustabad-Reyes, Federico Díaz-González |
| 20 |
[GO] |
2022―Mrz―18 |
Impact of Lung Ultrasound during the SARS-CoV-2 Pandemic: Distinction Between Viral and Bacterial Pneumonia |
Yale Tung-Chen, Alejandro Giraldo Hernández, Alberto Mora Vargas, Laura Dorado Doblado, Patricia Elsa González Merino, Ángela Valencia Alijo, Jesús Herraiz Jiménez, Ángela Gutiérrez Rojas, Sonia García Prieto, Edith Vanesa Gutiérrez Abreu, Esther Montero Hernández |
| 21 |
[GO] |
2022―Mrz―08 |
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study |
José Rosas, Francisco Pasquau Liaño, Mónica Llombart Cantó, José María Carrasco Barea, Amparo Raga Beser, José Tomás Algado Rabasa, Francisco Martínez Adsuar, Brian Vila Auli, Isabel Fernández López, Ana María Garijo Sainz, Pere Esquerdo Ramis, Laura Ruiz Pérez, Mª Luisa Navarrete Rebollo, Raquel Hernández Lorido, Laura Gómez Escolar |
| 22 |
[GO] |
2021―Dez―20 |
Recurrent pericarditis after Covid-19 |
David Rodrigo Domínguez, Amalia Rueda Cid, Cristina Campos Fernández, Clara Molina Almeda, Juan Jóse Lerma Garrido, M. Dolores Pastor Cubillo |
| 23 |
[GO] |
2021―Okt―29 |
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia |
Olga Sanchez-Pernaute, Fredeswinda I. Romero-Bueno, Albert Selva-O’Callaghan |
| 24 |
[GO] |
2021―Sep―16 |
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection |
Montserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, Inés Barreda-Altaba, María Nieto-Cid, Ana María Girona-Sanz, David El-Qutob |
| 25 |
[GO] |
2021―Sep―09 |
Hospitalization and Mortality from COVID-19 of Patients with Rheumatic Inflammatory Diseases in Andalusia |
Natalia Mena-Vázquez, Sara Manrique Arija, Marta Rojas-Giménez, Enrique Raya-Álvarez, María Luisa Velloso-Feijoó, C. López-Medina, Consuelo Ramos-Giraldez, Francisco Javier Godoy-Navarrete, Rocío Redondo-Rodríguez, Alba María Cabezas-Lucena, M. Morales-Águila, C.M. Romero-Barco, Antonio Fernández-Nebro |
| 26 |
[GO] |
2021―Jul―20 |
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients |
Giovanni Montealegre-Gómez, Edgar Garavito, Arley Gómez-López, Adriana Rojas-Villarraga, Rafael Parra-Medina |
| 27 |
[GO] |
2021―Jun―02 |
Tele-Rheumatology during the COVID-19 pandemic |
Jesús Tornero-Molina, Fernando Sánchez-Alonso, Manuel Fernández-Prada, María-Luisa Bris-Ochaita, Alberto Sifuentes-Giraldo, Javier Vidal-Fuentes |
| 28 |
[GO] |
2021―Jun―02 |
Impact of the COVID-19 pandemic on rheumatology nursing consultation |
Susana P. Fernández Sánchez, Fermín Rodríguez Muñoz, Ana Laiz, Ivan Castellví, Berta Magallares, Héctor Corominas |
| 29 |
[GO] |
2021―Apr―27 |
Teleconsultation of infant rheumatology in Covid-19 time |
Juan Carlos Nieto-González, Indalecio Monteagudo |
| 30 |
[GO] |
2021―Apr―14 |
Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19 |
Alejandro Muñoz-Jiménez, Esteban Rubio-Romero, José Luis Marenco de la Fuente |
| 31 |
[GO] |
2021―Mrz―23 |
Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper |
Lucía Mayordomo, Juan Molina Collada, Félix M. Francisco Hernández, Ángel Bueno, Santos A. Insua Vilariño, Francisco Gabriel Jiménez-Núñez, Rosalía Martínez Pérez, Ingrid Möller, Jacqueline Usón Jaeger, José Francisco García-Llorente, José M. Álvaro-Gracia, Eduardo Aparicio Ruiz, Liliana Asaro Daverio, Esperanza Naredo |
| 32 |
[GO] |
2020―Okt―16 |
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression |
Jairo Cajamarca-Baron, Diana Guavita-Navarro, Jhon Buitrago-Bohorquez, Laura Gallego-Cardona, Angela Navas, Hector Cubides, Ana María Arredondo, Alejandro Escobar, Adriana Rojas-Villarraga |
| 33 |
[GO] |
2020―Okt―15 |
Reumataxi: An experience of solidarity in times of COVID-19 |
Josep Blanch-Rubió, Jone Llorente-Onaindia, Pere Benito, Jordi Monfort |
| 34 |
[GO] |
2020―Okt―15 |
Inflammatory Response in Relation to COVID-19 and Other Prothrombotic Phenotypes |
José A. Páramo |
| 35 |
[GO] |
2020―Okt―15 |
Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective |
Claudia Mendoza-Pinto, Mario García-Carrasco, Pamela Munguía Realpozo, Socorro Méndez-Martínez |
| 36 |
[GO] |
2020―Okt―15 |
COVID-19: overview of rheumatology fellows |
Andrea Garcia-Guillén, Sicylle Jeria, David Lobo-Prat, Luís Sainz, Hèctor Corominas |
| 37 |
[GO] |
2020―Okt―15 |
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab |
Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Juan J. Cruz-Hernández |
| 38 |
[GO] |
2020―Okt―09 |
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology |
Lina María Saldarriaga Rivera, Daniel Fernández Ávila, Wilson Bautista Molano, Daniel Jaramillo Arroyave, Alain Jasaf Bautista Ramírez, Adriana Díaz Maldonado, Jorge Hernán Izquierdo, Edwin Jáuregui, María Constanza Latorre Muñoz, Juan Pablo Restrepo, Juan Sebastián Segura Charry |
| 39 |
[GO] |
2020―Jun―17 |
COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause |
Benjamin Fernandez-Gutierrez |
